Figure 3:Relative expression of IL-1β, iNOS and Arg-1 post transection with naked plasmid, Lipofectamine® complexed miR155 expressing plasmid DNA, blank multiple emulsion (BME), null
plasmid-encapsulated multiple emulsion (NME), and miR-155 plasmid DNA encapsulated multiple emulsion (MME). (*) p<0.05 statistically significant compared to cells treated with Lipofectamine® complexed plasmid DNA